ICD-10-CM Billable Code

D68.0

Von Willebrand disease

Clinical Classification Guidelines

Excludes Type 1

  • capillary fragility (hereditary) (D69.8)
  • factor VIII deficiency NOS (D66)
  • factor VIII deficiency with functional defect (D66)

Medical Intelligence & Overview

Von Willebrand disease is a common hereditary bleeding disorder caused by a deficiency or dysfunction of the von Willebrand factor, a protein essential for blood clotting. This condition affects the blood’s ability to form clots effectively, leading to prolonged or excessive bleeding. Although it can vary in severity, many individuals with this disease experience manageable symptoms, making awareness and proper management important.

Causes & Symptoms

Clinical Causes: Inherited genetic mutation affecting the production or function of von Willebrand factor Autosomal dominant inheritance pattern for most types, meaning only one copy of the mutated gene can cause the disorder Less commonly, recessive forms, which require mutations in both copies of the gene Family history of bleeding problems can often indicate a hereditary component

Key Symptoms: Easy bruising Frequent nosebleeds Excessive bleeding after minor cuts or injuries Heavy or prolonged menstrual periods Bleeding gums Blood in urine or stool in severe cases Swelling or pain at the site of internal bleeding In some cases, no symptoms are present, and the disorder is only discovered during medical evaluations or procedures

Diagnostic & Treatment

Diagnosis Path: Review of personal and family bleeding history Blood tests to measure levels of von Willebrand factor and factor VIII Bleeding time tests, such as the ristocetin cofactor assay, to evaluate platelet function Additional tests may include multimer analysis for detailed assessment of von Willebrand protein structure Exclusion of other bleeding disorders

Treatment Protocols: Desmopressin (DDAVP): a medication that stimulates release of von Willebrand factor from storage sites in the body, effective in many mild cases Replacement therapy with von Willebrand factor concentrates: used during surgery, significant blood loss, or in severe cases Antifibrinolytic medications: help prevent the breakdown of blood clots and are useful for mucosal bleeding like nosebleeds and heavy menstrual periods Avoiding medications that impair clotting, such as aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) Good management of bleeding episodes and preventive care, including dental hygiene and injury avoidance Regular follow-up with healthcare professionals for monitoring and tailored treatment plans

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is D68.0 a billable ICD-10 code?
Yes, D68.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report D68.0?
Clinical documentation must specify the nature of Von Willebrand disease and any associated comorbidities for accurate reporting.

Cite this Clinical Reference